Breast Cancer Treatment

Women who use insulin to treat their diabetes are more likely to have thick breasts, a risk factor for breast cancer, than women who use non-insulin drugs or follow lifestyle methods to control their diabetes, according to new research.

"Diabetic women on insulin need their medication, but they may benefit from additional breast cancer screening," said Zorana Andersen, Ph.D., associate professor of epidemiology at the University of Southern Denmark in Esbjerg. On March 8, she presented her findings at the 10th European Breast Cancer Conference. Medical conference research is typically regarded as preliminary until it is published in peer-reviewed medical journals.

"We know that diabetes raises the risk of breast cancer," Dr. Andersen adds. She and the other doctors, however, are unable to explain why this is the case. "The importance of insulin has been called into question," she says.

Insulin, according to Dr. Andersen, is a "growth-stimulating agent for all bodily tissues." As a result, the amount of epithelial or stromal tissue in the breast may rise, adding to an overall increase in breast density.

Explanation of Density

Breasts with thick tissue have less fatty tissue. Doctors divide breast density into four categories, ranging from virtually completely fatty to highly dense. The center contains breasts with dense and fatty tissues. Breast cancer detection becomes more difficult when dense breast tissue, such as tumors, appears white on mammography.

Obesity is common, according to the American Cancer Society. Although density decreases with age, this is not always the case. A woman's breast thickness cannot be determined only by size or firmness. She can ask her doctor to notify her about her breast density after a mammogram.

Women with the highest density (more than 75%) have a 4 to 6 times higher risk of breast cancer than those with the lowest density (less than 25%), according to specialists like Dr. Andersen.

What are the links between insulin, metformin, and diet?

The Danish study included 5,600 women, the vast majority of whom were approaching menopause. They were all, on average, 56 years old. All of them were participants in the Danish Diet, Cancer, and Health Study Group. They had mammograms between 1993 and 2001. Diabetes impacted 137 people or less than 3% of the entire population. She discovered that diabetic women were less likely to have thick or mixed breasts than overweight people.

To discover if they had fatty, rather than dense, breasts, the 44 people who used diet to control their diabetes were compared to the 62 persons who took drugs (such as metformin). Insulin users were found to be nearly twice as likely to have large breasts.

"We cannot conclude from this study if taking metformin affects breast density," she says. She claims that more research is require to fully understand the relationships she discovers.

Various Points of View

Two endocrinologists and a radiologist collaborated on the new study.

Gerald Bernstein, MD, former American Diabetes Association president and coordinator of the Friedman Diabetes Program at New York's Lenox Hill Hospital, predicted that the study's finding about insulin-treated women having larger breasts was correct. "Given insulin's function as a growth factor, that's not surprising," he says.

He does, however, warn that the research is preliminary. He recommends that metformin adding to the pharmacological regimen for insulin-treated women, "not so much for its glucose benefit as for its countering of the potential consequences of insulin," depending on the results of future research. Meanwhile, he agrees with Andersen on the significance of routine breast screening.

According to Wei Feng, MD, an endocrinologist and assistant clinical professor at City of Hope in Duarte, California, the discovery that insulin is linked to increased breast density is unlikely to be widely publicized. She, too, would like to see more research on metformin's impact on breast density.

The discovery is intriguing, but "it is too early to draw definite conclusions," says Debra Monticciolo, MD, a radiology professor at Texas A&M University and vice chair for research and section chief of breast imaging at Baylor Scott & White. Dr. Monticciolo, who also chairs the American College of Radiology's Commission on Breast Imaging, adds that if insulin use is found to be a significant risk factor, radiologists may consider placing it on the list of questions women are asked before their mammogram in order to identify risk.

'Will Eating Soy Foods Disrupt Hormones?'

A: A great deal of research has conduct on the best diets for long-term health and longevity. A plant-based Mediterranean diet is one definition of the Mediterranean diet. The Mediterranean diet is the most well-known and research diet that has been proven to be health-promoting.

You appear to be eating a Mediterranean-style diet, but it contains more soy than a true Mediterranean diet. The most common legumes found in a classic Mediterranean diet are lentils and chickpeas. However, in traditional Asian cultures, soy is the most commonly consume bean.

Lot of media hype about soy and its isoflavones (estrogen-like compounds found in soy) that haven't scientifically prove. Many studies have been conducted to shed light on the fears, as it is unknown how or why this link became so commonly believed.

Over the last two decades, more than 300 studies, both retrospective, and prospective, has conduct to investigate the link between soy consumption and breast cancer. They have a lower risk of breast cancer or recurrence when they consume soy. Women who ate more soy foods (such as soy milk, tofu, tempeh, and edamame) had a lower risk of breast cancer than those who ate little or no soy.

Obesity is the most common modifiable risk factor for breast cancer pills, as well as a substantial risk factor for a number of other cancers. Changes to a plant-rich diet, such as the Mediterranean diet with soy, Has show to prevent or reverse obesity as well as improve a number of other long-term health indicators. As a result, taking Arimidex Pill will not only reduce your chances of developing breast cancer but may even help prevent it.

What Is the Treatment for Breast Cancer?

Breast cancer can treatable in a variety of ways. It is identify by the type of breast cancer and the extent to which it has spread. Breast cancer patients typically receive more than one type of treatment.

•  
• A surgical procedure for removing cancerous tissue.
• Chemotherapy is the use of medicines to treat cancer cells. The drugs can administer orally, intravenously, or both.
• Hormone substitution therapy Cancer cells are the star of the hormones they need to develop.

Biological treatment. Helps your immune system fight cancer cells and manage the side effects of various cancer treatments.

Radiation treatment. To kill cancer cells, high-energy rays (similar to X-rays) using.

Breast cancer treatment by a multidisciplinary team of physicians. Surgeons are medical specialists who carry out surgical procedures. Medical oncologists are cancer specialists who treat patients with Anastrozole 1mg tablet. Radiation oncologists are cancer specialists who use radiation to treat patients.